APA citiranje

Aroldi, A., Chiarle, R., & Gambacorti-Passerini, C. (2021). Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019. Mayo Clin Proc.

Citação norma Chicago

Aroldi, Andrea, Roberto Chiarle, and Carlo Gambacorti-Passerini. "Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019." Mayo Clin Proc 2021.

MLA citiranje

Aroldi, Andrea, Roberto Chiarle, and Carlo Gambacorti-Passerini. "Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019." Mayo Clin Proc 2021.